Kintara Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch KTRA and buy or sell other stocks, ETFs, and their options commission-free!

About KTRA

TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. 

CEO
James A. Bianco, MD
CEOJames A. Bianco, MD
Employees
19
Employees19
Headquarters
Tampa, Florida
HeadquartersTampa, Florida
Founded
Founded
Employees
19
Employees19

KTRA Key Statistics

Market cap
5.23M
Market cap5.23M
Price-Earnings ratio
-0.05
Price-Earnings ratio-0.05
Dividend yield
Dividend yield
Average volume
146.03K
Average volume146.03K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$7.93
52 Week high$7.93
52 Week low
$1.80
52 Week low$1.80
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.